Predictive markers for development of strongyloidiasis in patients infected with both Strongyloides stercoralis and HTLV-1

Clinical and Experimental Immunology

Volumn 133, Issue 3, 2003, Pages 391-396

  Satoh, Masao ^a   Kiyuna, S ^b   Shiroma, Y ^b   Toma, H ^c   Kokaze, A ^d   Sato, Y ^c  

^a SAITAMA MEDICAL UNIVERSITY   (Japan)

^b Izumizaki Hospital   (Japan)

^c UNIVERSITY OF THE RYUKYUS   (Japan)

^d KYORIN UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

HTLV 1; HTLV 1 proviral load; S. stercoralis load; Strongyloidiasis

Indexed keywords

EPSTEIN BARR VIRUS ANTIGEN;

ADULT; ANTIBODY TITER; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; DISEASE MARKER; DISEASE PREDISPOSITION; FEMALE; HOST RESISTANCE; HUMAN; HUMAN T CELL LEUKEMIA VIRUS 1; INFECTION RISK; JAPAN; MALE; NONHUMAN; PREDICTION; PRIORITY JOURNAL; RISK ASSESSMENT; STRONGYLOIDES STERCORALIS; STRONGYLOIDIASIS; VIRUS DETECTION; VIRUS INFECTION; VIRUS LOAD;

ADULT; ANIMALS; ANTIBODIES, VIRAL; BIOLOGICAL MARKERS; DELTARETROVIRUS ANTIBODIES; EPSTEIN-BARR VIRUS NUCLEAR ANTIGENS; FECES; FEMALE; HTLV-I INFECTIONS; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; MALE; MIDDLE AGED; OPPORTUNISTIC INFECTIONS; RISK; STRONGYLOIDES STERCORALIS; STRONGYLOIDIASIS; VIRAL LOAD;

EID: 0042827575     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.2003.02224.x     Document Type: Article

References (41)

1. Yoshida M, Miyoshi I, Hinuma Y. Isolation and characterization of retro-virus from cell lines of human adult T cell leukemia and its implication in the disease. Proc Natl Acad Sci USA 1982; 79:2031-5.
2. Yoshida M, Seiki M, Yamaguchi K, Takatsuki K. Monoclonal integration of human T-cell leukemia provirus in all primary tumors of adult T-cell leukemia suggests causative role of human T-cell leukemia virus in the disease. Proc Natl Acad Sci USA 1984; 81:2534-7.
3. Gessain A, Barin F, Vernant JC, Gout O, Maurs L, Calender A, de The G. Antibodies to human T lymphotropic virus type-I in patients with tropic spastic paraparesis. Lancet 1985; 2:407-10.
4. Osame M, Usuku K, Izumo S, Ijichi N, Amitani H, Igata A, Matsumoto M, Tara M. HTLV-I-associated myelopathy, a new clinical entity. Lancet 1986; 1:1031-2.
5. Mochizuki M, Yamaguchi K, Takatsuki K, Watanabe T, Mon S, Tajima K. HTLV-I and uveitis. Lancet 1992; 339:1110.
6. Mochizuki M, Watanabe T, Yamaguchi K et al. An uveitis associated with human T-lymphotropic virus type-I (HTLV-I). seroepidemiological, clinical and virological studies. J Infect Dis 1992; 166:943-4.
7. Grove DI. Human Strongyloidiasis. Adv Parasitol 1996; 38:251-309.
8. Heyworth MF. Parasitic diseases in immunocompromised hosts. Criptosporidiosis, isosporiasis and strongyloidiasis. Gastroenterol Clin North Am 1996; 25:691-707.
9. Tajima K, Cartier L. Epidemiological features of HTLV-1 and adult T cell leukemia. Intervirol 1995; 38:238-46.
10. Plumelle Y, Pascaline N, Nguyen D, Panelatti G, Jouannelle A, Jouault H, Imbert M. Adult T-cell leukemia lymphoma. A clinico-pathologic study of twenty-six patients from Martinique. Hematol Pathol 1993; 7:251-62.
11. Satoh M, Tsukidate S, Fujita K, Yamamoto K. Strongyloidiasis influences the elevation of adult T-cell leukemia-associated antigen antibody titer. Int Arch Allergy Appl Immunol 1991; 96:95-6.
12. Furuya N, Shimoji K, Nakamura H et al. A case report of meningitis and sepsis due to Enterococcus faecium complicated with strongyloidiasis. Kansenshogaku Zasshi 1989; 63:1344-9.
13. Newton RC, Limpuangthip P, Greenberg S, Gam A, Neva FA. Strongyloides stercoralis hyperinfection in a carrier of HTLV-I virus with evidence of selective immunosuppression. Am J Med 1992; 92:202-8.
14. Adedayo AO, Grell GAC, Bellot P. Case study: Fatal strongyloidiasis associated with human T-cell lymphotropic virus type 1infection. Am J Trop Med Hyg 2001; 65:650-1.
15. Hinuma Y, Imai J. Epstein-Barr virus-specific antibodies in patients with adult T-cell leukemia (ATL) and healthy ATL virus-carriers. Int J Cancer 1983; 31:197-200.
16. Hayashi J, Kishihara Y, Yoshimura E, Furusho N, Yamaji K, Kawakami Y, Murakami H, Kashiwagi S. Correlation between human T cell lymphotropic virus type-1 and Strongyloides stercoralis infections and serum immunoglobulin E responses in residents of Okinawa. Japan Am J Trop Med Hyg 1997; 56:71-5.
17. Porto AF, Filho JO, Neva FA, Orge G, Alcantara L, Gam A, Carvalho EM. Influence of human T cell lymphotropic virus type-1 infection on serologic and skin tests for strongyloidiasis. Am J Trop Med Hyg 2001; 65:610-3.
18. Marsh BJ. Infectious complications oft cell leukemia/lymphoma virus type 1 infection. Clin Infect Dis 1996; 23:138-45.
19. Sato Y, Kobayashi J, Toma H, Shiroma Y. Efficacy of stool examination for detection of Strongyloides infection. Am J Trop Med Hyg 1995; 53:248-50.
20. Nakada K, Yamaguchi K, Furugen S et al. Monoclonal integration of HTLV-1 proviral DNA in patients with strongyloidiasis. Int J Cancer 1987; 40:145-8.
21. Arakaki T, Hasegawa H, Asato R, Ikeshiro T, Kinjo F, Saito A, Iwanaga M. A new method to detect Strongyloides stercoralis from human stool. Jpn J Trop Med Hyg 1988; 16:11-7.
22. Hinuma Y, Nagata K, Hanaoka M, Nakai M, Matsumoto T, Kinoshita KI, Shirakawa S, Miyoshi I. Adult T-cell leukemia. Antigen in an ATL cell line and detection of antibodies to the antigen in human sera. Proc Natl Acad Sci USA 1981; 78:6476-80.
23. Ono A, Mochizuki M, Yamaguchi K, Miyata N, Watanabe T. Increased number of circulatiing HTLV-1 infected cells in peripheral blood mononuclear cells of HTLV-1 uveitis patients: a quantitative polymerase chain reaction study. Br J Ophthalmol 1995; 79:270-6.
24. Reedman B, Klein G. Cellular localization of an Epstein-Barr virus (EBV)-associated compliment-fixing antigen in producer and non-producer lymphoblastoid cell lines. Int J Cancer 1973; 11:499-520.
25. Yamaguchi K, Kiyokawa T, Nakada K et al. Polyclonal integration of HTLV-1 proviral DNA in lymphocytes from HTLV-1 seropositive individuals: an intermediate state between the healthy carrier state and smouldering ATL. Br J Haematol 1988; 68:169-74.
26. Takatsuki K, Yamaguchi K, Watanabe T, Mochizuki M, Kiyokawa T, Mori S, Miyata N. Adult T-cell leukemia and HTLV-1 related diseases. In: Takatsuki K, Hinuma Y, Yoshida M, eds. Gann Monograph on Cancer Research. Tokyo: Kitagawa T, 1992:1-15.
27. Etoh K, Tamiya S, Yamaguchi K et al. Persistent clonal proliferation of human T-lymphotropic virus type I-infected cells in vivo. Cancer Res 1997; 57:4862-7.
28. Gabet AS, Mortreux F, Talarmin A et al. High circulating proviral load with oligoclonal expansion of HTLV-1 bearing T cells in HTLV-1 carriers with strongyloidiasis. Oncogene 2000; 19:4954-60.
29. Yamano Y, Nagai M, Brennan M et al. Correlation of human T-cell lymphotropic virus type 1 (HTLV-1) mRNA with proviral DNA load, virus-specific CD8+ T cells, and disease severity in HTLV-1-associated myelopathy (HAM/TSP). Blood 2002; 99:88-94.
30. Ishihara S, Okayama A, Stuver S et al. Association of HTLV-1 antibody profile of asymptomatic carriers with proviral DNA levels of peripheral blood mononuclear cells. J Acquir Immune Defic Syndr 1994; 7:199-203.
31. Henle W, Henle G. Epstein-Barr virus-specific serology in immunologically compromised individuals. Cancer Res 1981; 41:4222-5.
32. Nagafuchi S, Fujisaki T, Ohshima K et al. Immunodeficiency and carcinogenesis in patients with chronic active Epstein-Barr virus infection. Kansenshogaku Zasshi 1997; 71:56-64.
33. Bruu AL, Hjetland R, Holter E et al. Evaluation of 12 commercial tests for detection of Epstein-Barr virus-specific and heterophile antibodies. Clin Diagn Lab Immunol 2000; 7:451-6.
34. Osullivan CE, Peng R, Cole KS, Montelaro RC, Sturgeon T, Jenson HB, Ling PD. Epstein-Barr virus and human immunodeficiency virus serological responses and viral burdens in HIV-infected patients treated with HAART. J Med Virol 2002; 67:320-6.
35. Arakaki T, Asato R, Ikeshiro T, Sakiyama K, Iwanaga M. Is the prevalence of HTLV-1 infection higher in Strongyloides carriers than in non-carriers? Trop Med Parasitol 1992; 43:199-200.
36. Lessnau KD, Can S, Talavera W. Disseminated Strongyloides stercoralis in human immunodeficiency virus-infected patients. Treatment failure and a review of the literature. Chest 1993; 104:119-22.
37. Patey O, Gessain A, Breuil J et al. Seven years of recurrent severe strongyloidiasis in an HTLV-I infected man who developed adult T-cell leukaemia. AIDS 1992; 6:575-9.
38. Maekawa I, Kawamura T, Miyake T. Chronic adult T-cell leukemia (ATL) complicating disseminated strongyloidiasis. Rinsho Ketsueki 1988; 29:64-7.
39. Udaka M, Maehara N, Tamaki K et al. A case of Pneumocystis carinii pneumonia with hyperinfection of Strongyloides stercoralis complicated with smoldering adult T-cell leukemia. Kansenshogaku Zasshi 1990; 64:630-5.
40. Ishida H, Inoue T, Nishioka Y, Maruno K, Satoh M, Mishima Y, Furuse H. A case of biliary strongyloidiasis. J Jpn Soc Clin Surg 1991; 52:2151-5.
41. Ono A, Ikeda E, Mochizuki M et al. Provirus load in patients with human T-cell leukemia virus type 1 uveitis correlates with precedent Graves' disease and disease activities. Jpn J Cancer Res 1998;89:608-14.